Lilly Financial Results: Q4/FY 2019
On January 30, 2020, Lilly announced its financial results, including earnings, for the fourth quarter and full year of 2019.
"Lilly is in the early phase of an exciting period of growth for the company. The combination of strong revenue growth from our newer medicines and prudent expense control across our business enabled Lilly to invest more in our R&D pipeline and still deliver impressive earnings growth in the fourth quarter and full-year 2019," said Dave Ricks, Lilly's chairman and CEO. "We look forward to continuing this progress in 2020, as our scientists work to expand our portfolio of innovative medicines to offer new treatment options for patients in the areas of diabetes, oncology, immunology and neuroscience."
Read the press release
Listen to the investor webcast
Download the investor presentation
View Lilly's clinical development pipeline
Read Lilly executive committee biographies
- View Lilly's key facts
For more information, visit Lilly's Investor Relations website.